These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16127683)

  • 1. State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.
    Heerema NA; Bernheim A; Lim MS; Look AT; Pasqualucci L; Raetz E; Sanger WG; Cairo MS
    Pediatr Blood Cancer; 2005 Oct; 45(5):616-22. PubMed ID: 16127683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
    Burkhardt B; Oschlies I; Klapper W; Zimmermann M; Woessmann W; Meinhardt A; Landmann E; Attarbaschi A; Niggli F; Schrappe M; Reiter A
    Leukemia; 2011 Jan; 25(1):153-60. PubMed ID: 21030984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
    Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
    Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.
    Deffenbacher KE; Iqbal J; Sanger W; Shen Y; Lachel C; Liu Z; Liu Y; Lim MS; Perkins SL; Fu K; Smith L; Lynch J; Staudt LM; Rimsza LM; Jaffe E; Rosenwald A; Ott GK; Delabie J; Campo E; Gascoyne RD; Cairo MS; Weisenburger DD; Greiner TC; Gross TG; Chan WC
    Blood; 2012 Apr; 119(16):3757-66. PubMed ID: 22374697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
    Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
    Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N; Bernard V; Feller AC; Merz H
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.
    Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG
    Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
    Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
    Ma ES
    Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
    Miles RR; Cairo MS; Satwani P; Zwick DL; Lones MA; Sposto R; Abromovitch M; Tripp S; Angiolillo AL; Roman E; Davenport V; Perkins SL
    Br J Haematol; 2007 Aug; 138(4):506-12. PubMed ID: 17659054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom.
    Singh A; Obiorah IE
    Semin Diagn Pathol; 2023 Nov; 40(6):392-400. PubMed ID: 37400280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of non-Hodgkin's lymphomas in children.
    Perkins SL; Segal GH; Kjeldsberg CR
    Semin Diagn Pathol; 1995 Nov; 12(4):303-13. PubMed ID: 8578025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
    Poirel HA; Cairo MS; Heerema NA; Swansbury J; Aupérin A; Launay E; Sanger WG; Talley P; Perkins SL; Raphaël M; McCarthy K; Sposto R; Gerrard M; Bernheim A; Patte C;
    Leukemia; 2009 Feb; 23(2):323-31. PubMed ID: 19020548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.
    Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W
    Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.
    Cairo MS; Raetz E; Lim MS; Davenport V; Perkins SL
    Pediatr Blood Cancer; 2005 Nov; 45(6):753-69. PubMed ID: 15929129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.